Authors:
Bertheau, P
Plassa, LF
Lerebours, F
de Roquancourt, A
Turpin, E
Lidereau, R
de The, H
Janin, A
Citation: P. Bertheau et al., Allelic loss detection in inflammatory breast cancer: Improvement with laser microdissection, LAB INV, 81(10), 2001, pp. 1397-1402
Authors:
Ma, L
de Roquancourt, A
Bertheau, P
Chevret, S
Millot, G
Sastre-Garau, X
Espie, M
Marty, M
Janin, A
Calvo, F
Citation: L. Ma et al., Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions, J PATHOLOGY, 194(4), 2001, pp. 413-419
Authors:
Cottu, PH
Extra, JM
Espie, M
Marolleau, J
de Roquancourt, A
Makke, J
Miclea, JM
Laurence, V
Mayeur, D
Lerebours, F
Cuvier, C
Marty, M
Citation: Ph. Cottu et al., High-dose sequential epirubicin and cyclophosphamide with peripheral bloodstem cell support for advanced breast cancer: results of a phase II study, BR J CANC, 85(9), 2001, pp. 1240-1246
Authors:
de Labriolle-Vaylet, C
Cattan, P
Sarfati, E
Wioland, M
Billotey, C
Brocheriou, C
Rouvier, E
de Roquancourt, A
Rostene, W
Askienazy, S
Barbet, J
Milhaud, G
Gruaz-Guyon, A
Citation: C. De Labriolle-vaylet et al., Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery, CLIN CANC R, 6(2), 2000, pp. 363-371
Authors:
Sharifi-Salamatian, V
de Roquancourt, A
Rigaut, JP
Citation: V. Sharifi-salamatian et al., Breast carcinoma, intratumour heterogeneity and histological grading, using geostatistics, ANAL CELL P, 20(2-3), 2000, pp. 83-91
Authors:
Cottu, PH
Cojean-Zelek, I
Bourstyn, E
de Roquancourt, A
Extra, JM
Perret, F
Gorins, A
Marty, M
Espie, M
Citation: Ph. Cottu et al., Retrospective multivariate analysis of radio-pathological correlation of impalpable breast lesions. Hospital Saint-Louis's experience., REV MED IN, 21(4), 2000, pp. 337-343
Authors:
Turpin, E
Dalle, B
de Roquancourt, A
Plassa, LF
Marty, M
Janin, A
Beuzard, Y
de The, H
Citation: E. Turpin et al., Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers, ONCOGENE, 18(54), 1999, pp. 7834-7837